What is the recommended evaluation and stepwise management for constipation in a child without alarm features?

Management of Pediatric Constipation Without Alarm Features

Initial Assessment

A thorough history and physical examination, including digital rectal examination, should identify fecal impaction and rule out organic causes before initiating treatment. 1, 2

Key History Elements

• Stool frequency and consistency – fewer than 3 bowel movements per week or hard, painful stools suggest functional constipation 2, 3
• Pain-avoidance behaviors – standing on tiptoes, pressing heels into perineum, or hiding when feeling urge to defecate indicate withholding 3
• Age of onset – constipation beginning after the neonatal period is typically functional 4, 5
• Dietary history – assess fiber and fluid intake 2
• Toileting patterns – irregular or rushed bathroom habits contribute to withholding 2

Physical Examination Findings

• Abdominal palpation – a palpable fecal mass in the left lower quadrant confirms significant impaction 3
• Perianal inspection – look for anal fissures, skin tags, or abnormal anal position that cause pain-related withholding 3
• Digital rectal examination is essential to assess:
  • Anal sphincter tone (hypotonic suggests neurogenic cause; hypertonic suggests functional withholding)
  • Rectal vault size (dilation indicates chronic retention)
  • Presence and consistency of stool in the rectum
  • Anal wink reflex to exclude neurologic abnormalities 3

Red Flags Requiring Specialist Referral

• Delayed passage of meconium beyond 48 hours after birth (Hirschsprung disease) 3, 4
• Failure to thrive or poor weight gain 1, 4
• Severe abdominal distension 1, 4
• Ribbon stools or explosive stools 4, 6
• Rectal bleeding with systemic symptoms (requires colonoscopy to rule out inflammatory bowel disease) 3
• Cutaneous markers on lower back (dimples, hair tufts, hemangiomas) suggesting spinal dysraphism 3
• Absent anal wink or cremasteric reflex 6
• Tight, empty rectum on digital examination with explosive expulsion on finger withdrawal (Hirschsprung disease) 6, 5

Laboratory Testing

• No routine laboratory testing is needed when no alarm features are present 3
• If indicated by history, consider screening for hypothyroidism, hypercalcemia, hypokalemia, or diabetes mellitus 2, 3
• Abdominal X-ray is not routinely recommended 7

---

Stepwise Treatment Algorithm

Step 1: Disimpaction (If Fecal Impaction Present)

If digital rectal examination reveals impaction, disimpaction must be completed before maintenance therapy begins. 2, 6

Age-Specific Disimpaction Options:

Infants < 6 months:

• Glycerin suppositories as first-line 1, 2
• Manual disimpaction as alternative 2
• Avoid bisacodyl – no safety data in this age group 2

Infants 6-12 months:

• Fruit juices containing sorbitol (prune, pear, apple) at 10 mL/kg body weight 1, 2
• Lactulose if juices insufficient: approximately 5,670–11,340 mg per day (8–17 mL of 10 g/15 mL solution) for an 8.5 kg infant, titrated to produce soft stools 2
• Avoid lactulose preparations containing sorbitol preservative in very young infants due to hyperosmolar complications 2
• Glycerin suppositories if oral methods fail 1, 2

Children ≥ 1 year:

• Polyethylene glycol (PEG) 3350 at higher doses for disimpaction 2, 6
• Glycerin suppositories or manual disimpaction 2
• Contraindications to suppositories/enemas: neutropenia, thrombocytopenia, recent colorectal surgery, anal trauma, severe colitis 2

---

Step 2: Maintenance Therapy

Polyethylene glycol (PEG) 3350 is the first-line maintenance laxative for children ≥ 6 months old. 2, 6

Dosing and Goals:

• Initial dose: 0.8–1 g/kg/day 2
• Goal: 2–3 soft, painless stools daily 2, 3
• Duration: Continue for at least 2 months, often many months before normal bowel motility returns 2, 6, 8

Alternative Laxatives (if PEG unavailable or poorly tolerated):

• Lactulose as preferred alternative 2, 6
• Avoid stool softeners alone (docusate) – ineffective for constipation 2

When to Add Stimulant Laxatives:

• If no response to optimal PEG therapy after 3–6 months, add senna or bisacodyl suppositories 30 minutes after a meal 3
• Stimulant laxatives should not be used as first-line monotherapy 2

Critical Warnings During PEG Treatment:

• Stop PEG immediately if: rectal bleeding, nausea, bloating, cramping, abdominal pain, or diarrhea develop 2

---

Step 3: Non-Pharmacological Interventions

Behavioral modifications and dietary changes are essential adjuncts to pharmacological therapy. 2, 4, 8

Behavioral Modifications:

• Establish regular toileting schedule: voiding in the morning, twice during school, after school, at dinner, and before bed 2
• Correct toilet posture: secure seating with buttock support, foot support, and comfortable hip abduction 2
• Reward systems for successful toileting 4, 8
• Recognize and address withholding behaviors 4

Dietary Interventions:

• Increase dietary fiber: approximately (age + 5) grams per day, though evidence for efficacy is limited 3
• High-fiber foods include fruits, vegetables, whole grains, legumes 2
• Maintain adequate hydration 2
• Avoid excessive juice consumption – can cause diarrhea, flatulence, abdominal pain, and poor weight gain 1

Special Dietary Considerations:

• For infants with suspected cow's milk protein intolerance: trial extensively hydrolyzed or amino acid-based formula for 2–4 weeks 1
• 24% of formula-fed infants with constipation may respond to protein hydrolysate formula 1
• Do not dilute infant formula – does not help constipation and compromises nutrition 1

---

Step 4: Monitoring and Follow-Up

Close, long-term follow-up is essential because constipation is a chronic condition with frequent relapses. 2, 4, 8

Monitoring Parameters:

• Stool frequency and consistency 2
• Absence of pain with defecation 2
• Weight gain and growth parameters 2
• Bowel diary for at least 1 week provides objective data 3

When to Adjust Treatment:

• If symptoms persist despite adequate PEG therapy for 3–6 months, add stimulant laxative 3
• If still refractory, refer for anorectal manometry to assess for pelvic-floor dyssynergia 3
• Biofeedback therapy may benefit children > 4 years with documented dyssynergic defecation 3

---

Step 5: Weaning and Long-Term Management

Premature discontinuation of treatment is a common pitfall – maintenance therapy must continue for many months. 2, 8

• Gradual tapering of laxatives as bowel habits normalize 2
• 40–50% of children relapse within 5 years if maintenance therapy is stopped too soon 2
• Full continence may not be achieved until the second decade 2

---

Special Populations and Considerations

Constipation with Urinary Symptoms

• Treating constipation resolves bladder emptying abnormalities in 66% of children with dysfunctional voiding 3
• In children with both constipation and urinary symptoms, constipation-focused therapy resolves daytime wetting in 89% and nighttime wetting in 63% 3
• Aggressive constipation management decreases urinary tract infections and reduces need for intervention in vesicoureteral reflux 2, 3

Genetic Syndromes

• Williams syndrome: chronic lifelong constipation requiring aggressive therapy; complications include rectal prolapse, hemorrhoids, intestinal perforation, and early-onset diverticulitis 3

Neonates (≤ 1 month)

• Increase feeding frequency to 8–10 sessions per 24 hours – associated with higher stool frequency 1
• Gentle clockwise abdominal massage and warm baths may help 1
• Avoid routine rectal stimulation – can lead to dependence and mucosal trauma 1
• Refer if symptoms persist despite conservative management for 4–8 weeks 1

---

Common Pitfalls to Avoid

• Relying solely on dietary changes without addressing impaction worsens constipation 2
• Using stimulant laxatives as first-line therapy instead of osmotic agents 2
• Premature discontinuation of treatment before the child regains normal bowel motility and rectal perception 2
• Failing to treat concomitant constipation in children with enuresis makes it difficult to achieve dryness 9
• Introducing multiple changes simultaneously obscures response to any single intervention 1